1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Shareholder votes
Announces Closing of up to $20.4 Million Public Offering
Majority Shareholder Approves Reverse Stock Split of Up to 1-for-20
Other Events
Director Retirement - Dr. Andrew Keller Will Not Seek Reelection
Sunshine Biopharma Enters $4M At-The-Market Sales Agreement with Aegis Capital
Sunshine Biopharma Enters $1.5 Million Settlement with Former Subsidiary Pres...
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
S-1
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Preliminary Information Statement
Definitive Information Statement
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Post-Effective Amendment to Registration Statement